MTS Transaction Experience

$16.4 million

PIPE Financing

Biopharmaceuticals

NA

Acquisition

Managed Care

Up to $105 million

Acquisition of Biopharmaceuticals Company

Biopharmaceuticals

$26 Million

PIPE Financing

Specialty Pharmaceuticals

NA

Acquisition

Healthcare IT

NA

Recapitalization

Healthcare IT

NA

Sale of Long Term Care Real Estate Portfolio

Healthcare Real Estate

NA

Sale

Long Term Care Laboratory

$45 million

PIPE Financing and Strategic Partnership

Biopharmaceuticals

$28 million

PIPE Financing

Biopharmaceuticals

$95 Million

Sale of Women's Health Business

Specialty Pharmaceuticals

$275 million

Sale

Providers - Long Term/Post Acute Care

$225 million

Sale of Pharmacy Services Division

Specialty Pharmaceuticals

$61.1 million

Follow-On-Offering

Biopharmaceuticals

$24 million

PIPE Financing

Specialty Pharmaceuticals

$1.3 billion

Acquisition of Hospital System

Managed Care

$285 million

Reverse Merger

Biopharmaceuticals

$26 million

Sale

OTC Pharmaceuticals

$35 million

PIPE Financing

Specialty Pharmaceuticals

$45 Million

Convertible Notes

Biotechnology

$15 million

PIPE Financing

Biotechnology

NA

Acquisition of Hospice System

Providers - Long Term/Post Acute Care

$22.5 million

Follow On Public Offering

Biotechnology

$7 million

Bridge Financing

Biotechnology

$1.6 billion

Spin-Off of Real Estate Assets into a Separately Traded Entity

Providers - Long Term/Post Acute Care

$238 million

Follow-On-Offering

Providers - Long Term/Post Acute Care

NA

Sale

Specialty Pharmaceuticals

$450 million

Financial advisory services for licensing deal

Biotechnology

Up to $140 million

Sale

Biotechnology

$50 million

Initial Public Offering

Specialty Pharmaceuticals

$73 million

Restructuring

Diagnostic Laboratory

$17 million

Private Placement

Healthcare Information Technology

$23 million

PIPE

Biotechnology

$35 million

PIPE

Biotechnology

$15 million

Refinancing

Pharmaceuticals

$11 - 27 million

Sale

Biotechnology

$37 million

Divestiture

Managed Care

$213 million

Refinancing / Public Exchange Offer

Specialty Pharmaceuticals

$15 million

PIPE

Biotechnology

$40 million

Private Placement

Biotechnology

$30 million

Private Placement

Biotechnology

$18 million

PIPE

Biotechnology

NA

Sale

Outsourcing/Other Services

$350 million

Sale

Providers - Alternate Site

$625 million

Acquisition

Providers - Long Term/Post Acute Care

$630 million

Acquisition

Managed Care

$125 million

Acquisition

Managed Care

NA

Divestiture

Providers - Alternate Site

$19 million

Sale

Providers - Long Term/Post Acute Care

$240 million

Acquisition

Managed Care

NA

Divestiture

Providers - Alternate Site

$9 billion

Sale

Managed Care

NA

Sale

Managed Care

$246 million

Acquisition

Providers - Long Term/Post Acute Care

NA

Acquisition

Managed Care

$135 million

Restructuring

Providers - Alternate Site

NA

Divestiture

Providers - Alternate Site

$532 million

Acquisition

Managed Care

$45 million

Sale

Managed Care

$1.4 billion

Restructuring

Providers - Long Term/Post Acute Care

$200 million

Structured Financing

Managed Care

$150 million

Divestiture

Managed Care

$75 million

PIPE

Providers - Long Term/Post Acute Care

$90 million

Sale

Providers - Long Term/Post Acute Care

$200 million

Financing

Managed Care

$126 million

Debt Acquisition

Providers - Alternate Site

$250 million

Debt Financing

Managed Care

$1.4 billion

Sale

Pharmaceuticals - Generic